Clinical Trials

41 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT05101564 2026-02-12

Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer

19 enrolled 10 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT03879577 2026-01-21

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

53 enrolled 13 charts

Breast Neoplasms

NCT02668666 2026-01-20

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

49 enrolled 14 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT01196936 2026-01-05

LDTam

84 enrolled 17 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT02764541 2025-05-07

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

195 enrolled 26 charts

Breast Neoplasms, Carcinoma, Lobular

NCT02040857 2025-04-29

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

162 enrolled 12 charts

Breast Neoplasms

NCT03219476 2025-04-29

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

37 enrolled 10 charts

Breast Neoplasms

NCT03346200 2025-03-07

KARISMA2

1,440 enrolled 14 charts

Breast Neoplasms, Risk Reduction Behavior

NCT03691493 2025-02-17

ASPIRE

36 enrolled 17 charts

Breast Neoplasms

NCT04079517 2025-02-06

Karisma-1

Phase 1/2 Completed

42 enrolled 6 charts

Breast Neoplasms

NCT01897441 2024-12-24

Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

Phase NA Terminated

31 enrolled 11 charts

Breast Neoplasms

NCT02993159 2024-12-18

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

100 enrolled 15 charts

Phase EARLY_PHASE1 Completed

Carcinoma, Intraductal, Noninfiltrating

NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

7 enrolled 13 charts

Breast Neoplasms

NCT04129216 2024-05-07

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

30 enrolled 10 charts

Breast Neoplasms

NCT04190056 2023-08-31

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

1 enrolled 4 charts

Anatomic Stage IV Breast Cancer AJCC v8

NCT02269670 2022-04-05

Phase II Study of Everolimus Beyond Progression

3 enrolled 4 charts

Breast Neoplasms

NCT02384239 2022-03-16

A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

70 enrolled 16 charts

Breast Neoplasms

NCT00710970 2022-01-24

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

28 enrolled 8 charts

Genitourinary

Urinary Bladder Neoplasms

NCT02586675 2022-01-21

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Phase 1 Completed

7 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT02988986 2021-09-22

ANETT

28 enrolled 9 charts

Breast Neoplasms

NCT02936206 2021-05-19

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Phase 1 Terminated

2 enrolled 5 charts

Breast Neoplasms

NCT02197897 2021-01-13

BCTamoxifen

15 enrolled 5 charts

Genitourinary

Urinary Bladder Neoplasms

NCT02395627 2020-07-07

Reversing Therapy Resistance With Epigenetic-Immune Modification

38 enrolled 18 charts

Breast Neoplasms

NCT02291913 2020-02-17

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

48 enrolled 13 charts

Breast Neoplasms

NCT00687102 2018-09-12

Co-STAR

Phase 3 Completed

1,498 enrolled 13 charts

Breast Neoplasms

NCT01614210 2018-08-01

POWER PIINC

52 enrolled 9 charts

Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

50 enrolled 13 charts

Breast Neoplasms

NCT00873366 2018-01-23

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Terminated

92 enrolled 20 charts

Breast Neoplasms

NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

45 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01027416 2017-12-13

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Phase NA Completed

59 enrolled 10 charts

Breast Neoplasms

NCT00764322 2017-08-01

NRR

501 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT02806544 2017-01-30

Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

35 enrolled 9 charts

Breast Neoplasms

NCT00293540 2016-07-27

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Phase 3 Completed

249 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01293032 2016-07-12

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Phase NA Completed

59 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01896050 2016-06-28

LOGRIBMET

Completed

115 enrolled 14 charts

BreastOther

Breast Neoplasms, Obesity, Arthralgia

NCT00952731 2015-07-21

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

27 enrolled 12 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00999921 2015-05-18

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Phase 4 Completed

256 enrolled 8 charts

Cystic Fibrosis, Fibrocystic Breast Disease, Fibroadenoma, Mastodynia

NCT00201851 2015-04-29

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Phase 3 Completed

740 enrolled 14 charts

Breast Neoplasms

NCT01194908 2015-01-26

Re-expression of ER in Triple Negative Breast Cancers

Phase 1/2 Terminated

5 enrolled 5 charts

Breast Neoplasms

NCT00365599 2014-11-21

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

43 enrolled 8 charts

Breast Neoplasms, Neoplasm Metastasis, Bulbo-Spinal Atrophy, X-Linked

NCT00183963 2014-05-22

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

4 enrolled 8 charts

Breast Neoplasms

NCT01194427 2013-05-17

A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

2 enrolled 3 charts